Xinqiao Hospital Of Chongqing

This early-stage study is testing a new mRNA-based immunotherapy for cancers associated with the Epstein-Barr virus (EBV), such as certain lymphomas and nasopharyngeal cancer. The study will enroll 40 adults to see if the treatment is safe and if it helps control the disease, eit…

This early-stage study is testing a new mRNA therapy designed to treat several autoimmune diseases that haven't responded well to other treatments. The therapy uses technology similar to some COVID-19 vaccines to deliver instructions that target a specific part of the immune syst…

This study is testing whether adding a medication called eptifibatide helps people recover better after receiving standard clot-busting treatment for a stroke. It focuses on patients who get treatment 4.5 to 24 hours after symptoms begin and who aren't improving well. The main go…